![Graham Bell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Dr. Bell joined us in November 1998 as Project Manager and has served as General Manager, Polgen Division since 2000.
He was previously Head of Cell Culture with Biocure Ltd.
(now Medysis plc) a biotech company spun out of Aberdeen University.
He holds a B.Sc.
and Ph.D.
from Edinburgh University.
Antiguos cargos conocidos de Graham Bell.
Empresas | Cargo | Fin |
---|---|---|
Cyclacel Group Plc
![]() Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Corporate Officer/Principal | 15/10/2008 |
Formación de Graham Bell.
The University of Edinburgh | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Cyclacel Group Plc
![]() Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Health Technology |
- Bolsa de valores
- Insiders
- Graham Bell